Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 75, Issue 3, 1992, Pages 820-825

  Matikainen, Tiina ^a   Ding, Ying Qing ^a   Vergara, Marcela ^a   Huhtaniemi, Ilpo ^a   Couzinet, Beatrice ^b   Schaison, Gilbert ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DETIRELIX; FOLLITROPIN; LUTEINIZING HORMONE; TRIPTORELIN;

ADULT; AGED; ARTICLE; BIOASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLITROPIN BLOOD LEVEL; GRANULOSA CELL; HORMONE RESPONSE; HUMAN; HUMAN TISSUE; IMMUNORADIOMETRIC ASSAY; IMMUNOREACTIVITY; INTRAMUSCULAR DRUG ADMINISTRATION; LEYDIG CELL; LUTEINIZING HORMONE BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; BIOLOGICAL ASSAY; COMPARATIVE STUDY; FEMALE; FOLLICLE STIMULATING HORMONE; GONADORELIN; HUMAN; IMMUNORADIOMETRIC ASSAY; LUTEINIZING HORMONE; MENOPAUSE; MIDDLE AGE; OSMOLAR CONCENTRATION; SUPPORT, NON-U.S. GOV'T;

EID: 0026669620     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.75.3.1517372     Document Type: Article

References (56)

1. Matsuo H, Baba Y, Nair R, Arimura A, Schally A. 1971 Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem Biophys Res Commun. 43:1334-9.
2. Burgus R, Butcher M, Amoss M, et al. 1972 Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF). Proc Natl Acad Sci USA. 69:278-82.
3. Rivier C, Rivier J, Vale W. 1980 Antiproductive effects of a potent gonadotropin-releasing hormone antagonist in the male rat. Science. 210:93-9.
4. Jennes L, Stumpf W, Conn PM. 1984 Receptor-mediated binding and uptake of GnRH agonist and antagonist by pituitary cells. Peptides. 5(Suppl):215-20.
5. Davis MR, Veldhuis JD, Rogol AD, Dufau ML, Catt KJ. 1987 Sustained inhibitory actions of a potent antagonist of gonadotropinreleasing hormone in postmenopausal women. J Clin Endocrinol Metab. 64:1268-74.
6. Pavlou SN, Interlandi JW, Wakefield G, et al. 1987 Gonadotropins and testosterone escape from suppression during prolonged luteinizing hormone-releasing hormone antagonist administration in normal men. J Clin Endocrinol Metab. 64:1070-4.
7. Mortola JF, Sathanandan M, Pavlou S, et al. 1989 Suppression of bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone levels by a potent gonadotropin-releasing hormone antagonist; pharmacodynamic studies. Fertil Steril. 52:95763.
8. Clayton RN. 1981 Gonadotropin-releasing hormone modulation of its own pituitary receptors: evidence for biphasic regulation. Endocrinology 111:152-61.
9. Bhasin S, Swerdloff RS. 1986 Mechanisms of gonadotropin-releasing hormone agonist action in human male. Endocr Rev. 7:96-114.
10. Labrie F, Dupont A, Blanger A, et al. 1986 Treatment of prostate cancer with gonadotropin-releasing hormone agonist. Endocr Rev. 7:67-74.
11. Hazum E, Conn PM. 1988 Molecular mechanism of gonadotropin releasing hormone (GnRH) action. I. The GnRH receptor. Endocr Rev. 9:379-86.
12. Huckle WA, Conn PM. 1988 Molecular mechanism of gonadotropin releasing hormone action. II. The effector system. Endocr Rev. 9:387-95.
13. Clayton RN. 1989 Gonadotropin-releasing hormone: its actions and receptors. J Endocrinol. 120:119.
14. Healy DL, Lawson SR, Abbott M, Baird DT, Fraser HM. 1986 Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase. J Clin Endocrinol Metab. 63:619-25.
15. Meldrum DR, Tsao Z, Monroe SE, et al. 1984 Stimulation of LH fragment with reduced bioactivity following GnRH agonist administration in women. J Clin Endocrinol Metab. 58:755-7.
16. Chiang R-S, Barnes RB, Shoupe D, Lobo RA. 1985 Dose-related changes in LH bioactivity with intranasal GnRH agonist administration. Contraception. 32:347-57.
17. Calogero AE, Macchi M, Montanini V, et al. 1987 Dynamics of plasma gonadotropin and sex steroid release on polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone. J Clin Endocrinol Metab. 64:980-5.
18. 6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary-testicular axis in patients with prostatic cancer. J Clin Invest. 71:1842-53.
19. St Arnaud RM, Lachance R, Dupont A, Labrie F. 1986 Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and on estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen. J Clin Endocrinol Metab. 63:297-302.
20. Jaakkola T, Ding Y-Q, Kellokumpu-Lehtinen P, et al. 1990 The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: réévaluation by a highly sensitive immunometric assay. J Clin Endocrinol Metab. 70:1496-505.
21. Huhtaniemi I, Venho P, Jacobi G, Rannikko S. 1991 Response of circulating gonadotropin levels to GnRH agonist treatment in prostatic cancer. J Androl. 12:46-53.
22. Huhtaniemi IT, Dahl KD, Rannikko S, Hsueh AJW. 1988 Serum bioactive and immunoreactive follicle-stimulating hormone in prostatic cancer patients during gonadotropin-releasing hormone agonist treatment and after orchidectomy. J Clin Endocrinol Metab. 66:30813.
23. Pavlou SN, Dahl KD, Wakefield G, et al. 1988 Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration. J Clin Endocrinol Metab. 66:10059.
24. Berga SL, Galway RA, Kaufman S, Jones KL, Maintenance of the FSH bioactive (B) to immunoreactive (I) ratio in girls with central precocious puberty during GnRH agonist therapy [Abstract 1717], Proc of the 71st Annual Meet of The Endocrine Soc. 1989.
25. Dahl KD, Pavlou SN, Kovacs WJ, Hsueh AJW. 1986 The changing ratio of serum bioactive to immunoreactive follicle-stimulating hormone in normal men following treatment with a potent gonadotropin releasing hormone antagonist. J Clin Endocrinol Metab. 63:7924.
26. Dahl KD, Bicsak TA, Hsueh AJW. 1988 Naturally occurring antihormones: secretion of FSH antagonists by women treated with a GnRH analog. Science. 239:72-4.
27. Kessel B, Dahl KD, Kazer RR, et al. 1988 The dependency of bioactive follicle-stimulating hormone secretion on gonadotropin releasing hormone in hypogonadal and cycling women. J Clin Endocrinol Metab. 66:361-6.
28. Pavlou SN, Wakefield G, Schlechter NL, et al. 1989 Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men. J Clin Endocrinol Metab. 68:446-54.
29. Haavisto A-M, Dunkel L, Pettersson K, Huhtaniemi I. 1990 LH measurements by in vitro bioassay and a highly sensitive immuno-fluorometric assay improve the distinction between boys with constitutional delay of puberty and hypogonadotropic hypogonadism. Pediatr Res. 27:211-4.
30. Apter D, Cacciatore B, Alfthan H, Stenman U-H. 1989 Serum luteinizing hormone concentrations increase 100-fold in females from 7 years of age to adulthood, as measured by time-resolved immunofluorometric assay. J Clin Endocrinol Metab. 68:53-7.
31. DeHertogh R, Wolter R, Van Vliet G, Vankrieken L. 1989 Serum gonadotropin levels in childhood: critical comparisons between im-munoradiometric assays and radioimmunoassays. Acta Endocrinol (Copenh). 121:141-6.
32. Wennink JMB, Delemarre-van de Waal HA, van Kessel H, Mulder GH, Foster JP, Schoemaker J. 1988 Luteinizing hormone secretion patterns in boys at the onset of puberty measured using a highly sensitive immunoradiometric assay. J Clin Endocrinol Metab. 67:924-8.
33. Couzinet B, Lahlou N, Thomas G, et al. 1991 Effects of gonadotropin releasing hormone antagonist and agonist on the pulsatile release of gonadotropins and a-subunit in postmenopausal women. Clin Endocrinol (Oxf). 34:477-83.
34. Rivier JE, Porter J, Rivier CL, et al. 1986 New effective gonadotropin-releasing hormone antagonist with minimal potency for histamine release in vitro. J Med Chem. 29:1846-51.
35. 6 luteinizing hormone-releasing hormone from injectable microcapsules. Proc Natl Acad Sci USA. 81:5845-8.
36. Lahlou N, Delivet S, Bardin W, Roger M, Spitz IM, Bouchard P. 1990 Changes in gonadotropin and a-subunit secretion after a single administration of gonadotropin-releasing hormone antagonist in adult males. Fertil Steril. 5:898-905.
37. Couzinet B, Le Strat N, Brailly S, Schaison G. 1986 Comparative effects of cyproterone acetate or a long acting gonadotropin releasing hormone agonist in polycystic ovarian disease. J Clin Endocrinol Metab. 63:1031-5.
38. Lahlou N, Roger M, Chaussain JL, et al. 1987 Gonadotropin and a-subunit secretion during long term pituitary suppression by D-TrpMuteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty. J Clin Endocrinol Metab. 65:946-53.
39. Jia X-C, Hsueh AJW. 1985 Sensitive in vitro bioassay for the measurement of serum follicle-stimulating hormone. Nendocrinol-ogy. 41:445-8.
40. La X-C, Hsueh AJW. 1986 Granulosa cell aromatase bioassay for follicle-stimulating hormone: validation and application of the method. Endocrinology. 119:1570-7.
41. Jia X-C, Kessel B, Yen SSC, Tucker EM, Hsueh AJW. 1986 Serum bioactive follicle-stimulating hormone during the human menstrual cycle, in hyper- and hypogonadotropic states: application of a sensitive granulosa cell aromatase bioassay (GAB). J Clin Endocrinol Metab. 62:1243-9.
42. Reddi K, Wickings EJ, Baird DT, Hillier SG. 1988 A sensitive bioassay for follicle stimulating hormone in human serum. J Endocrinol. 119(Suppl):117.
43. Reddi K, Wickings EJ, McNeilly AS, Baird DT, Hillier SG. 1990 Circulating bioactive follicle stimulating hormone and immunore-active inhibin levels during the normal human menstrual cycle. Clin Endocrinol (Oxf). 33:547-57.
44. Hsueh AJW, Wang C, Erickson GF. 1980 Direct inhibitory effect of gonadotropin-releasing hormone upon follicle-stimulating hormone induction of luteinizing hormone receptor and aromatase activity in rat granulosa cells. Endocrinology. 106:1697-705.
45. Van Damme M-P, Robertson DM, Diczfalusy E. 1974 An improved in vitro bioassay method for measuring luteinizing hormone (LH) activity using mouse Leydig cell preparations. Acta Endocrinol (Copenh). 77:655-71.
46. Ding Y-Q, Huhtaniemi I. 1989 Human serum LH binding inhibi-tor(s): behaviour and contribution to in vitro bioassay of LH using dispersed mouse Leydig cells. Acta Endocrinol (Copenh). 121:4654.
47. Wang C. 1988 Bioassays of follicle stimulating hormone. Endocr Rev. 9:374-7.
48. Dufau ML, Beitins IZ, McArthur JW, Catt KJ. 1976 Effects of luteinizing hormone releasing hormone (LHRH) upon bioactive and immunoreactive serum LH levels in normal subjects. J Clin Endocrinol Metab. 43:658-67.
49. Marrama P, Zaidi AA, Montanini V, et al. 1982 Age and sex related variation in biologically active and immunoreactive serum luteinizing hormone. J Endocrinol Invest. 6:427-33.
50. Dufau ML, Veldhuis JD, Fraioli F, Johnson ML, Beitins IZ. 1983 Mode of secretion of bioactive luteinizing hormone in men. J Clin Endocrinol Metab. 57:993-1000.
51. Veldhuis JD, Johnson ML, Dufau ML. 1987 Preferential release of bioactive luteinizing hormone in response to endogenous, low dose exogenous gonadotropin-releasing hormone pulses in man. J Clin Endocrinol Metab. 64:1275-82.
52. Talbot JA, Rodger RSC, Shalet SM, Littley MD, Robertson WR. 1990 The pulsatile secretion of bioactive luteinizing hormone in normal adult men. Acta Endocrinol (Copenh.). 122:643-50.
53. Huhtaniemi I, Ding Y-Q, Tàhtela R, Vàlimàki M. 1992. The bio/immuno ratio of plasma LH does not change during the endogenous secretion pulse; reanalysis of the concept using improved immunoassay techniques. J Clin Endocrinol Metab, In press.
54. Pavlou SN, Wakefield GB, Kamlaris TC, Lender J, Island DP, Kovacs WJ, Clinical studies using "Nal-Glu' a new LHRH antagonist [Abstract 914], Proc of the 69th Annual Meet of The Endocrine Soc. 1987.
55. Davis MR, Veldhuis JD, Rogol AD, Dufau ML, Catt KJ. 1987 Sustained inhibitory actions of a potent antagonist of gonadotropin releasing hormone in postmenopausal women. J Clin Endocrinol Metab. 64:1268-74.
56. Bhasin S, Robinson R, Peterson M, et al. 1984 Molecular heterogeneity and biological activity of LH after GnRH agonist treatment. Fertil Steril. 42:318-9.